Treatment (Tx) patterns, efficacy and safety of eribulin for advanced and heavily pretreated breast cancer (ABC): Updated results from a single-center, real-world study. This is an ASCO Meeting ...
Oncologists rationale for testing PD-L1 expression levels in patients with disease states where PD-L1 testing is not part of the IO product specific indications. Phase 1 open-label trial to evaluate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results